Filtered By:
Management: Insurance
Nutrition: Calcium
This page shows you your search results in order of date.
Order by Relevance | Date
Total 80 results found since Jan 2013.
Comparative Analysis of First-Line FOLFOX Treatment With and Without Anti-VEGF Therapy in Metastatic Colorectal Carcinoma: A Real-World Data Study
CONCLUSION: Our real-world data analysis suggests that the addition of anti-VEGF to FOLFOX offers limited and short-lived benefits in the context of mCRC and may provide differential survival benefit based on tumor sidedness.PMID:37724508 | DOI:10.1177/10732748231202470
Source: Cancer Control - September 19, 2023 Category: Cancer & Oncology Authors: Ronen Brenner Shlomit Amar-Farkash Avital Klein-Brill Keren Rosenberg-Katz Dvir Aran Source Type: research
One-year persistence of renin-angiotensin-aldosterone system inhibitors fixed drug combinations in hypertensive patients
CONCLUSIONS: The authors have demonstrated that the one-year persistence of RAAS inhibitor FDCs varies significantly in hypertensive patients. ACE inhibitor/CCB FDCs were found to be the most advantageous. Orv Hetil. 2023; 164(34): 1337-1341.PMID:37634155 | DOI:10.1556/650.2023.32840
Source: Orvosi Hetilap - August 27, 2023 Category: General Medicine Authors: G ábor Simonyi Tam ás Ferenci Ervin Finta Mih ály Medvegy Istv án Wittmann Source Type: research
The potential impact of computed tomography coronary calcium score screening on patients with dyslipidemia
CONCLUSION: CAC scoring is associated with reduced risk of myocardial infarction and death in asymptomatic dyslipidemia patients and should be considered as a screening tool in these patients. The presumed mechanism for improved outcomes is that early identification of CAD results in earlier or more intensive treatment, reducing future cardiac event risk.PMID:37614860 | PMC:PMC10444005 | DOI:10.1080/08998280.2023.2239083
Source: Baylor University Medical Center Proceedings - August 24, 2023 Category: Universities & Medical Training Authors: Brittany Miles Bunnarin Theng Bright O Etumuse Atefeh Zeinoddini Arsalan Saleem Source Type: research
Precision therapy for a medically actionable ATP1A3 variant from a genomic medicine program in an underserved population
CONCLUSION: In retrospect, his symptomatology matches the known medical conditions associated with the ATP1A3 gene namely Alternating Hemiplegia of Childhood 2 (AHC), a rare autosomal dominant disorder with an incidence of 1 in one million. His single nucleotide variant, (c.2401G>A, p.D801N), is predicted to be damaging. The specific amino acid change p.D801N has been previously reported in ClinVar along with the allelic variant p.D801Y and both are considered pathogenic. The identification of this variant altered medical management for this patient as he was started on a calcium antagonist and has reported no further h...
Source: Molecular Medicine - August 24, 2023 Category: Molecular Biology Authors: Cara P Ford Rebecca O Littlejohn Ryan German Blake Vuocolo Jose Aceves Liesbeth Vossaert Nichole Owen Michael Wangler Carrie A Schmid Texome Project Source Type: research
The potential impact of computed tomography coronary calcium score screening on patients with dyslipidemia
CONCLUSION: CAC scoring is associated with reduced risk of myocardial infarction and death in asymptomatic dyslipidemia patients and should be considered as a screening tool in these patients. The presumed mechanism for improved outcomes is that early identification of CAD results in earlier or more intensive treatment, reducing future cardiac event risk.PMID:37614860 | PMC:PMC10444005 | DOI:10.1080/08998280.2023.2239083
Source: Baylor University Medical Center Proceedings - August 24, 2023 Category: Universities & Medical Training Authors: Brittany Miles Bunnarin Theng Bright O Etumuse Atefeh Zeinoddini Arsalan Saleem Source Type: research
Precision therapy for a medically actionable ATP1A3 variant from a genomic medicine program in an underserved population
CONCLUSION: In retrospect, his symptomatology matches the known medical conditions associated with the ATP1A3 gene namely Alternating Hemiplegia of Childhood 2 (AHC), a rare autosomal dominant disorder with an incidence of 1 in one million. His single nucleotide variant, (c.2401G>A, p.D801N), is predicted to be damaging. The specific amino acid change p.D801N has been previously reported in ClinVar along with the allelic variant p.D801Y and both are considered pathogenic. The identification of this variant altered medical management for this patient as he was started on a calcium antagonist and has reported no further h...
Source: Molecular Medicine - August 24, 2023 Category: Molecular Biology Authors: Cara P Ford Rebecca O Littlejohn Ryan German Blake Vuocolo Jose Aceves Liesbeth Vossaert Nichole Owen Michael Wangler Carrie A Schmid Texome Project Source Type: research
